• Hyperglycosylated chorionic gonadotropin – prognostic criteria development of complications of pregnancy

Hyperglycosylated chorionic gonadotropin – prognostic criteria development of complications of pregnancy

HEALTH OF WOMAN. 2017.5(121):82–85; doi 10.15574/HW.2017.121.82 

Pehnyo N. V.
National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev

The objective: to assess the prognostic significance of the level of serum hyperglycosylated human chorionic gonadotropin (gHCG) reative to the development of pregnancy complications that lead to impaired fetal conditions.

Materials and methods. 382 pregnant women were examined who were on the register, were hospitalized in case of complications of pregnancy and gave birth to KCMH №2 (Kiev). All pregnant women were evaluated serum gCGG in the period of 8-10 weeks gestation, evaluated the course and result of pregnancy.

Results. Reduction in the level of gHCG is a marker of insufficient trophoblast invasion, which is likely to lead to the formation of placental dysfunction and the development of a variety of obstetric pathology complicating the course of pregnancy and a risk factor for antenatal loss and neonatal morbidity.

The conclusion. Determination of the level of hyperglycosylated human chorionic gonadotropin in the first trimester of pregnancy will make it possible to identify pregnant women at risk for the formation of placental dysfunction and propose a set of monitoring activities aimed at early detection of violations of pregnancy and their timely removal. This helps prevent the formation of severe pathological conditions during pregnancy in both the mother and the fetus, which corresponds to the current trends in the development of medical care, namely: prediction, prevention and individual approach.

Key words: hyperglycosylated chorionic gonadotrophin, complications of pregnancy, disturbed fetal condition.

References

1. Kokranovskoe rukovodstvo: beremennost i rody. M, «Logosfera». 2010:146–148.

2. Brosens I, Pijnenborg R, Vercruysse L & Romero R. 2011. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. Am J ObstetGynecol 204:193–201. https://doi.org/10.1016/j.ajog.2010.08.009; PMid:21094932 PMCid:PMC3369813

3. Costa MA. 2016. The endocrine function of human placenta: an overview. ReprodBiomedOnline 32:14–43. https://doi.org/10.1016/j.rbmo.2015.10.005

4. Sferruzzi-Perri AN & Camm EJ. 2016. The Programming Power of the Placenta. FrontPhysiol 7:33. https://doi.org/10.3389/fphys.2016.00033; PMid:27014074 PMCid:PMC4789467

5. Brosens I, Pijnenborg R, Vercruysse L & Romero R. 2011. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. Am J ObstetGynecol 204:193–201. https://doi.org/10.1016/j.ajog.2010.08.009; PMid:21094932 PMCid:PMC3369813

6. Chappell LC & David AL. 2016. Improving the Pipeline for Developing and Testing Pharmacological Treatments in Pregnancy. PLoS Med 13:e1002161. https://doi.org/10.1371/journal.pmed.1002161; PMid:27802279 PMCid:PMC5089678

7. Cole LA, Khanlian SA, Kohorn LI. 2008. Evolusion of the human brain? Chorionic gonadotropin and gemochorial implantation of the placenta: insights into origins of pregnancy failures, Preeclampsia, choriocarcinoma. J Reprod Med 53:449–557.

8. Daniele Bolla, M.D. Andrea Papadia, M.D., Ph.D. Luigi Raio, M.D. 2016. The sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 374:1785-1786 May 5, 2016. PMid:27144855

9. Cole LA. 2009. hCG and hyperhly-cosylatedhCG in the establishment and evolution on hemochorial placentation. J ReprodImmunol 82:111–7. https://doi.org/10.1016/j.jri.2009.04.007; PMid:19560212

10. Berger P, Sturgeon C, Bidart JM, Paus E, Gerth R, Niang M, Bristow A, Birken S, Stenman UH. 2002. The ISOBM TD7 Workshop on hCG and related molecules. Towards useroriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the threedimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumour Biol. 23;1:138.

11. Cole LA. 1997. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem. 43;12:2233–2243. PMid:9439438

12. Cole L, Butler S. 2002. Detection of hCG in Trophoblastic disease. The USA hCg reference Service Experience. J.Reprod Med. 47:433–444. PMid:12092011

13. Butler SA, Khanlian SA, Cole LA. 2001. Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. Clin Chem. 47;12:2131–2136. PMid:11719477

14. O’Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. 1998. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. PrenatDiagn. 18:1232–1240. https://doi.org/10.1002/(SICI)1097-0223(199812)18:12<1232::AID-PD439>3.0.CO;2-Z